BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Bio NC

  Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day

  Pfizer Inc. invites investors and the general public to access a live video webcast of its Oncology Innovation Day on Thursday, February 29, 2024, from 1:00 p.m. EST to 5:30 p.m. EST, with an approximately 20-minute break at the midpoint.

  February 15, 2024

   · 

  4 min read
• Pharm Country

  Beyond Celiac Launches First Investment Program for Celiac Disease Therapeutics

  Beyond Celiac announces the creation of Beyond Celiac Investments, an investment program to accelerate the development of treatments and a cure for celiac disease by leveraging the speed and scale of venture capital and capital markets.

  February 15, 2024

   · 

  3 min read
• Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

  Trinity Biotech Plc. announced that it has finalized the effective date of its ratio change of its American depositary shares from one ADS representing four Class A ordinary shares to one ADS representing twenty Class A ordinary shares.

  February 15, 2024

   · 

  3 min read
• Business

  Poxel Reports Cash and Revenue for the Full Year 2023 and Provides Corporate Update

  POXEL SA announced its cash position and revenue and provided a corporate update for the twelve months ended December 31, 2023.

  February 15, 2024

   · 

  10 min read
• Policy

  Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution)

  Pyros Pharmaceuticals, Inc. announced the positive outcome of the Decentralised Procedure for VIGZIP™ in Europe.

  February 15, 2024

   · 

  2 min read
• Galapagos presents at EBMT-EHA annual meeting 2024

  Galapagos NV to present new preliminary translational data and previously disclosed data at the European Society for Blood and Marrow Transplantation -European Hematology Association 6th European CAR T-cell meeting taking place from 15–17 February 2024 in Valencia, Spain.

  February 15, 2024

   · 

  14 min read
• Lone Star Bio

  Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs

  Taysha Gene Therapies, Inc. provided an update on its deprioritized pipeline programs as part of an ongoing effort to help support their further potential development.

  February 15, 2024

   · 

  4 min read
• QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification

  QIAGEN announced two significant achievements in sustainability through recognitions by My Green Lab, a non-profit organization dedicated to advancing sustainability in scientific research:

  February 15, 2024

   · 

  6 min read
• Business

  Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update

  Nurix Therapeutics, Inc. reported financial results for the fiscal quarter and fiscal year ended November 30, 2023, and provided a corporate update.

  February 15, 2024

   · 

  15 min read
• Business

  Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

  Ultragenyx Pharmaceutical Inc. reported its financial results for the quarter and full year ended December 31, 2023 and reaffirmed its financial guidance for 2024.

  February 15, 2024

   · 

  14 min read